Adial Pharmaceuticals, Inc. (ADIL, AZR)
CIK 1513525 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adial Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 4, 2026 | 4 | 0001213900-26-115983 |
| Nov 4, 2026 | 4 | 0001213900-26-115985 |
| Nov 3, 2026 | 4 | 0001104659-26-121891 |
| Nov 3, 2026 | SCHEDULE 13G/A | 0001104659-26-121888 |
| Oct 30, 2026 | 3 | 0001213900-26-114575 |
| Oct 30, 2026 | 3 | 0001213900-26-114578 |
| Oct 30, 2026 | 4 | 0001213900-26-114588 |
| Oct 28, 2026 | 8-K | 0001213900-26-113337 |
| Oct 26, 2026 | EFFECT | 9999999995-26-003343 |
| Oct 21, 2026 | S-3/A | 0001213900-26-111112 |
| Oct 21, 2026 | 10-Q/A | 0001213900-26-111121 |
| Oct 16, 2026 | DEFA14A | 0001213900-26-110352 |
| Oct 16, 2026 | 8-K | 0001213900-26-110349 |
| Oct 5, 2026 | DEFA14A | 0001213900-26-106577 |
| Oct 2, 2026 | 8-K | 0001213900-26-106395 |
| Sep 21, 2026 | 4 | 0001213900-26-101883 |
| Sep 18, 2026 | DEFA14A | 0001213900-26-101500 |
| Sep 18, 2026 | 8-K | 0001213900-26-101434 |
| Sep 16, 2026 | 8-K | 0001213900-26-100574 |
| Sep 16, 2026 | DEFA14A | 0001213900-26-100607 |
| Aug 28, 2026 | S-8 | 0001213900-26-095119 |
| Aug 28, 2026 | S-3 | 0001213900-26-095122 |
| Aug 25, 2026 | 8-K | 0001213900-26-093544 |
| Aug 24, 2026 | DEF 14A | 0001213900-26-093019 |
| Aug 24, 2026 | ARS | 0001213900-26-093022 |